Literature DB >> 11830947

Occurrence and transferability of beta-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava.

H Bujdáková1, J Hanzen, S Jankovicová, J Klimácková, M Moravcíková, P Milosovic, D Michálková-Papajová, J Kallová, A Jakab, M Kettner.   

Abstract

Occurrence and transferability of beta-lactam resistance in 30 multi-resistant Escherichia coli, Klebsiella spp., Enterobacter spp., Pantoea agglomerans, Citrobacter freundii and Serratia marcescens strains isolated from children between 0 and 3 years of age is presented. The strains were resistant to ampicillin (30), cefoxitin (22), cefotaxime (30), ceftriaxone (30), ceftazidime (30) and aztreonam (28), but susceptible to cefepime (30) and imipenem (26). Twenty-eight of 30 isolates possessed a transferable resistance confirmed by conjugation and isolation of 79-89-kb plasmids. The beta-lactam resistance was due to production of beta-lactamases and ceftazidime proved to be stronger beta-lactamase inductor than ceftriaxone. Twenty-five clinical isolates expressed transferable extended spectrum beta-lactamases, and chromosomally encoded AmpC beta-lactamase.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11830947     DOI： 10.1007/bf02815624

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  33 in total

1.  Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; J Lopez; A Pechinot; A Kazmierczak
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 2.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

3.  Reevaluating practice changes: return to standard precautions after an outbreak of multidrug-resistant Klebsiella oxytoca.

Authors:  K M Giramonti; L A Johnson-Robbins; D L Weatherwax; M J Horgan
Journal:  J Nurs Care Qual       Date:  2000-01       Impact factor: 1.597

4.  Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Authors:  L Martínez-Martínez; A Pascual; S Hernández-Allés; D Alvarez-Díaz; A I Suárez; J Tran; V J Benedí; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

Review 6.  Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.

Authors:  F Lindberg; S Normark
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

7.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

8.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

Authors:  P A Bradford; C Urban; N Mariano; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

9.  Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

Authors:  C Peña; M Pujol; C Ardanuy; A Ricart; R Pallares; J Liñares; J Ariza; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

10.  Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae.

Authors:  T W Huber; J S Thomas
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948
View more
  7 in total

1.  [Soft tissue infections in oral, maxillofacial, and plastic surgery. Bacterial spectra and antibiotics].

Authors:  A W Eckert; P Maurer; D Wilhelms; J Schubert
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

2.  Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Authors:  Martina Zarnayová; Eliane Siebor; André Péchinot; Jean-Marie Duez; Helena Bujdáková; Roger Labia; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Occurrence of endemic plasmids causing beta-lactam resistance in Enterobacteriaceae in children's university hospital in Munich.

Authors:  S Benczeová; D Adam; M Vrábelová; D Michálková-Papajová; M Kettner
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Occurrence of plasmid-mediated ampicillin resistance among enterobacteria from the ovine rumen.

Authors:  R Malík; P Pristas; P Javorský
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Occurrence of extended-spectrum beta-lactamases among Escherichia coli isolates from hospitalized and healthy children.

Authors:  R Franiczek; B Sobieszczańska; M Grabowski; K Mowszet; T Pytrus
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

6.  Extended-spectrum beta-lactamase-conferring transferable resistance to different antimicrobial agents in Enterobacteriaceae isolated from bloodstream infections.

Authors:  R Franiczek; B Krzyzanowska; I Dolna; G Mokracka; K Szufnarowski
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

7.  Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae.

Authors:  Xuan Qin; Scott J Weissman; Mary Frances Chesnut; Bei Zhang; Lisong Shen
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-07-15       Impact factor: 3.944
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.